Double-blind experiment (at random) comparative of the efficacy of ketotifen and Clemastina, for the treatment of periodic allergic Rhinitis. The study embraced 40 patients (21 men and 19 women) between 13 and 57 years old. The program was conducted on a fifty-fifty shares between both drugs. The clinic efficacy of ketotifen has been proved either as regards to clinic improvement or the less good results attained with the use of clemastine. The AA. guess on the prophylactic influence of ketotifen in asthmatic bronchial crisis among patients suffering allergic rhinitis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas.
Mol Cancer Ther
November 2024
Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, Cyprus.
Article Synopsis
- Sarcomas are rare and complex cancers originating in soft tissues or bones, making their treatment difficult due to a challenging tumor microenvironment (TME) that limits drug delivery.
- A study tested the drug ketotifen in combination with advanced chemotherapy and immunotherapy techniques in mouse models, which showed that ketotifen improved the TME by reducing tumor stiffness and increasing blood flow, leading to better treatment outcomes.
- This treatment combination also enhanced immune response by increasing the presence of effective T-cells and altering macrophage activity, suggesting a promising approach for improving therapeutic efficacy in sarcoma patients.
Biomechanical outcomes of pharmacological therapies for post-traumatic arthrofibrosis in preclinical animal models: a systematic review and meta-analysis.
Connect Tissue Res
July 2024
Upper Limb Surgery Unit, Orthopaedics and Traumatology Department, La Paz University Hospital, Madrid, Spain.
Purpose/aim Of The Study: There is still no evidence of which drug has the greatest therapeutic potential for post-traumatic arthrofibrosis. The aim of this study is to systematically review the literature for quality evidence and perform a meta-analysis about the pharmacological therapies of post-traumatic arthrofibrosis in preclinical models.
Materials And Methods: A comprehensive and systematic search strategy was performed in three databases (MEDLINE, EMBASE and Web of Science) retrieving studies on the effectiveness of pharmacological therapies in the management of post-traumatic arthrofibrosis using preclinical models in terms of biomechanical outcomes.
interaction of naphthoquine with ivermectin, atovaquone, curcumin, and ketotifen in the asexual blood stage of 3D7.
Microbiol Spectr
July 2024
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Unlabelled: Naphthoquine is a promising candidate for antimalarial combination therapy. Its combination with artemisinin has demonstrated excellent efficacy in clinical trials conducted across various malaria-endemic areas. A co-formulated combination of naphthoquine and azithromycin has also shown high clinical efficacy for malaria prophylaxis in Southeast Asia.
View Article and Find Full Text PDFEfficacy and safety of different systemic drugs in the treatment of uremic pruritus among hemodialysis patients: a network meta-analysis based on randomized clinical trials.
Front Med (Lausanne)
April 2024
Department of Nephrology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
Article Synopsis
- This network meta-analysis aimed to evaluate and rank the effectiveness and safety of various systemic drugs for treating uremic pruritus (UP) in patients on hemodialysis.
- It involved a review of 22 randomized controlled trials (RCTs), analyzing drugs such as gabapentin, cromolyn sodium, and hydroxyzine for their impact on pruritus relief and adverse effects.
- The findings suggest that gabapentin is the most effective treatment for UP, while cromolyn sodium presents lower risks of adverse events, indicating it may be a safer option for some patients.
Article Synopsis
- This study looked at how a treatment called electroacupuncture (EA) can help rats with a diarrhea-related tummy problem known as irritable bowel syndrome (IBS-D).
- The researchers tested this treatment by checking how many loose stools the rats had and how sensitive their tummies were when poked.
- The results showed that EA helped the rats by making their loose stools less frequent and reducing inflammation in their intestines, which means it might help protect their tummy lining.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!